Psychosocial Needs for Newly Diagnosed Youth with Type 1 Diabetes and Their Families

Miller GF, Coffield E, Leroy Z, Wallin R. Prevalence and costs of five chronic conditions in children. J Sch Nurs. 2016;32(5):357–64.

PubMed  PubMed Central  Article  Google Scholar 

Saydah SH, Imperatore G, Henkin L, D’Agostino R Jr, Divers J, Mayer-Davis EJ, et al. Trends and characteristics of self-reported case presentation of diabetes diagnosis among youth from 2002 to 2010: findings from the SEARCH for diabetes in youth study. Diabetes Care. 2015;38(6):e84–5.

PubMed  PubMed Central  Article  Google Scholar 

Mayer-Davis EJ, Dabelea D, Lawrence JM. Incidence trends of type 1 and type 2 diabetes among youths, 2002–2012. N Engl J Med. 2017;377(3):301.

PubMed  PubMed Central  Article  Google Scholar 

Patterson CC, Karuranga S, Salpea P, Saeedi P, Dahlquist G, Soltesz G, et al. Worldwide estimates of incidence, prevalence and mortality of type 1 diabetes in children and adolescents: results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract. 2019;157:107842.

Barrett CE, Koyama AK, Alvarez P, Chow W, Lundeen EA, Perrine CG, et al. Risk for newly diagnosed diabetes >30 days after SARS-CoV-2 infection among persons aged <18 tears - United States, March 1, 2020-June 28, 2021. MMWR Morb Mortal Wkly Rep. 2022;71(2):59–65.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Unsworth R, Wallace S, Oliver NS, Yeung S, Kshirsagar A, Naidu H, et al. New-onset type 1 diabetes in children during COVID-19: multicenter regional findings in the U.K. Diabetes Care. 2020;43(11):e170-e1.

Vlad A, Serban V, Timar R, Sima A, Botea V, Albai O, et al. Increased incidence of type 1 diabetes during the COVID-19 pandemic in Romanian children. Medicina (Kaunas). 2021;57(9):973.

PubMed  PubMed Central  Article  Google Scholar 

Mortensen HB, Hougaard P, Swift P, Hansen L, Holl RW, Hoey H, et al. New definition for the partial remission period in children and adolescents with type 1 diabetes. Diabetes Care. 2009;32(8):1384–90.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Committee of the American Diabetes Association Professional Practice. 14. Children and adolescents: standards of medical care in diabetes- 2022. Diabetes Care. 2022;45:S208-S31.

Whittemore R, Jaser S, Chao A, Jang M, Grey M. Psychological experience of parents of children with type 1 diabetes: a systematic mixed-studies review. Diabetes Educ. 2012;38(4):562–79.

PubMed  PubMed Central  Article  Google Scholar 

DiMeglio LA, Acerini CL, Codner E, Craig ME, Hofer SE, Pillay K, et al. ISPAD Clinical Practice Consensus Guidelines 2018: glycemic control targets and glucose monitoring for children, adolescents, and young adults with diabetes. Pediatr Diabetes. 2018;19(Suppl 27):105–14.

PubMed  Article  Google Scholar 

Albers JW, Herman WH, Pop-Busui R, Feldman EL, Martin CL, Cleary PA, et al. Effect of prior intensive insulin treatment during the Diabetes Control and Complications Trial (DCCT) on peripheral neuropathy in type 1 diabetes during the Epidemiology of Diabetes Interventions and Complications (EDIC) Study. Diabetes Care. 2010;33(5):1090–6.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Diabetes Control, Complications Trial /Epidemiology of Diabetes I, Complications Research G, Lachin JM, White NH, Hainsworth DP, et al. Effect of intensive diabetes therapy on the progression of diabetic retinopathy in patients with type 1 diabetes: 18 years of follow-up in the DCCT/EDIC. Diabetes. 2015;64(2):631–42.

Cengiz E, Cheng P, Ruedy KJ, Kollman C, Tamborlane WV, Klingensmith GJ, et al. Clinical outcomes in youth beyond the first year of type 1 diabetes: results of the Pediatric Diabetes Consortium (PDC) type 1 diabetes new onset (NeOn) study. Pediatr Diabetes. 2017;18(7):566–73.

CAS  PubMed  Article  Google Scholar 

Cengiz E, Connor CG, Ruedy KJ, Beck RW, Kollman C, Klingensmith GJ, et al. Pediatric diabetes consortium T1D New Onset (NeOn) study: clinical outcomes during the first year following diagnosis. Pediatr Diabetes. 2014;15(4):287–93.

CAS  PubMed  Article  Google Scholar 

Sherr JL, Schwandt A, Phelan H, Clements MA, Holl RW, Benitez-Aguirre PZ, et al. Hemoglobin A1c patterns of youth with type 1 diabetes 10 years post diagnosis from 3 continents. Pediatrics. 2021;148(2):e2020048942. https://doi.org/10.1542/peds.2020-048942Identifies similar HbA1c trajectories in youth with type 1 diabetes from multiple international registries and how trajectories in the new-onset period may relate to future trajectories.

Schwandt A, Hermann JM, Rosenbauer J, Boettcher C, Dunstheimer D, Grulich-Henn J, et al. Longitudinal trajectories of metabolic control from childhood to young adulthood in type 1 diabetes from a large German/Austrian registry: a group-based modeling approach. Diabetes Care. 2017;40(3):309–16.

PubMed  Article  Google Scholar 

Prahalad P, Yang J, Scheinker D, Desai M, Hood K, Maahs DM. Hemoglobin A1c trajectory in pediatric patients with newly diagnosed type 1 diabetes. Diabetes Technol Ther. 2019;21(8):456–61.

PubMed  PubMed Central  Article  Google Scholar 

Patton SR, Feldman K, Majidi S, Noser A, Clements MA. Identifying HbA1c trajectories and modifiable risk factors of trajectories in 5- to 9-year-olds with recent-onset type 1 diabetes from the United States. Diabet Med. 2021;38(9):e14637. Provides preliminary evidence of psychosocial factors that may predict child HbA1c trajectories in youth with new-onset type ! diabetes.

Davis AK, DuBose SN, Haller MJ, Miller KM, DiMeglio LA, Bethin KE, et al. Prevalence of detectable C-Peptide according to age at diagnosis and duration of type 1 diabetes. Diabetes Care. 2015;38(3):476–81.

CAS  PubMed  Article  Google Scholar 

Rickels MR, Evans-Molina C, Bahnson HT, Ylescupidez A, Nadeau KJ, Hao W, et al. High residual C-peptide likely contributes to glycemic control in type 1 diabetes. J Clin Invest. 2020;130(4):1850–62.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Gubitosi-Klug RA, Braffett BH, Hitt S, Arends V, Uschner D, Jones K, et al. Residual beta cell function in long-term type 1 diabetes associates with reduced incidence of hypoglycemia. J Clin Invest. 2021;131(3):e143011. https://doi.org/10.1172/JCI143011.

Writing Committee for the Type 1 Diabetes TrialNet Oral Insulin Study G, Krischer JP, Schatz DA, Bundy B, Skyler JS, Greenbaum CJ. Effect of oral insulin on prevention of diabetes in relatives of patients with type 1 diabetes: a randomized clinical trial. JAMA. 2017;318(19):1891–902.

Herold KC, Gitelman SE, Ehlers MR, Gottlieb PA, Greenbaum CJ, Hagopian W, et al. Teplizumab (anti-CD3 mAb) treatment preserves C-peptide responses in patients with new-onset type 1 diabetes in a randomized controlled trial: metabolic and immunologic features at baseline identify a subgroup of responders. Diabetes. 2013;62(11):3766–74.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Perdigoto AL, Preston-Hurlburt P, Clark P, Long SA, Linsley PS, Harris KM, et al. Treatment of type 1 diabetes with teplizumab: clinical and immunological follow-up after 7 years from diagnosis. Diabetologia. 2019;62(4):655–64.

CAS  PubMed  Article  Google Scholar 

Haller MJ, Long SA, Blanchfield JL, Schatz DA, Skyler JS, Krischer JP, et al. Low-dose anti-thymocyte globulin preserves C-peptide, reduces HbA1c, and increases regulatory to conventional T-cell ratios in new-onset type 1 diabetes: two-year clinical trial data. Diabetes. 2019;68(6):1267–76. This is a clinical trial of a promising immune modulating therapy for children with new-onset type 1 diabetes to prolong partial remission.

Haller MJ, Schatz DA, Skyler JS, Krischer JP, Bundy BN, Miller JL, et al. Low-dose anti-thymocyte globulin (ATG) preserves beta-cell function and improves HbA1c in new-onset type 1 diabetes. Diabetes Care. 2018;41(9):1917–25.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Jamiolkowska-Sztabkowska M, Glowinska-Olszewska B, Luczynski W, Konstantynowicz J, Bossowski A. Regular physical activity as a physiological factor contributing to extend partial remission time in children with new onset diabetes mellitus-Two years observation. Pediatr Diabetes. 2020;21(5):800–7. This is a clinical trial of a promising behavioral treatment for children with new-onset type 1 diabetes to prolong partial remission.

Robertson K, Riddell MC, Guinhouya BC, Adolfsson P, Hanas R, International Society for P, et al. ISPAD Clinical Practice Consensus Guidelines 2014. Exercise in children and adolescents with diabetes. Pediatr Diabetes. 2014;15 Suppl 20:203–23.

Kumar S, Kumar R, Rohilla L, Jacob N, Yadav J, Sachdeva N. A high potency multi-strain probiotic improves glycemic control in children with new-onset type 1 diabetes mellitus: a randomized, double-blind, and placebo-controlled pilot study. Pediatr Diabetes. 2021;22(7):1014–22.

CAS  PubMed  Article  Google Scholar 

Buckingham B, Beck RW, Ruedy KJ, Cheng P, Kollman C, Weinzimer SA, et al. Effectiveness of early intensive therapy on beta-cell preservation in type 1 diabetes. Diabetes Care. 2013;36(12):4030–5.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Duca LM, Reboussin BA, Pihoker C, Imperatore G, Saydah S, Mayer-Davis E, et al. Diabetic ketoacidosis at diagnosis of type 1 diabetes and glycemic control over time: The SEARCH for diabetes in youth study. Pediatr Diabetes. 2019;20(2):172–9.

CAS  PubMed  Article  Google Scholar 

Mencher SR, Frank G, Fishbein J. Diabetic ketoacidosis at onset of type 1 diabetes: rates and risk factors today to 15 years ago. Glob Pediatr Health. 2019;6:2333794X19870394.

Baldelli L, Flitter B, Pyle L, Maahs DM, Klingensmith G, Slover R, et al. A survey of youth with new onset type 1 diabetes: opportunities to reduce diabetic ketoacidosis. Pediatr Diabetes. 2017;18(7):547–52.

PubMed  Article  Google Scholar 

DiMeglio LA. COVID-19 and type 1 diabetes: addressing concerns and maintaining control. Diabetes Care. 2021;44(9):1924–8.

CAS  PubMed  Article  Google Scholar 

McGlacken-Byrne SM, Drew SEV, Turner K, Peters C, Amin R. The SARS-CoV-2 pandemic is associated with increased severity of presentation of childhood onset type 1 diabetes mellitus: a multi-centre study of the first COVID-19 wave. Diabet Med. 2021;38(9): e14640.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Duca LM, Wang B, Rewers M, Rewers A. Diabetic ketoacidosis at diagnosis of type 1 diabetes predicts poor long-term glycemic control. Diabetes Care. 2017;40(9):1249–55.

CAS  PubMed  Article  Google Scholar 

Zaharieva DP, Addala A, Prahalad P, Bishop F, Hood K, Maahs D. Youth with type 1 diabetes benefit from early continuous glucose monitoring initiation irrespective of diabetic ketoacidosis at diagnosis: 4T pilot study results. 15th International Conference on Advanced Technologies & Treatments for Diabetes April Barcelona, Spain 2022.

Aye T, Mazaika PK, Mauras N, Marzelli MJ, Shen H, Hershey T, et al. Impact of early diabetic ketoacidosis on the developing brain. Diabetes Care. 2019;42(3):443–9.

PubMed  Article  Google Scholar 

Ghetti S, Kuppermann N, Rewers A, Myers SR, Schunk JE, Stoner MJ, et al. Cognitive function following diabetic ketoacidosis in children with new-onset or previously diagnosed type 1 diabetes. Diabetes Care. 2020;43(11):2768–75.

PubMed  PubMed Central  Article  Google Scholar 

Semenkovich K, Bischoff A, Doty T, Nelson S, Siller AF, Hershey T, et al. Clinical presentation and memory function in youth with type 1 diabetes. Pediatr Diabetes. 2016;17(7):492–9.

CAS  PubMed  Article  Google Scholar 

Lawson S, Redel JM, Smego A, Gulla M, Schoettker PJ, Jolly M, et al. Assessment of a day hospital management program for children with type 1 diabetes. JAMA Netw Open. 2020;3(3): e200347.

PubMed  PubMed Central  Article  Google Scholar 

Pingul MM, Mulvihill EM, Reinert SE, Gopalakrishnan G, Plante WA, Boney CM, et al. Pediatric diabetes outpatient center at Rhode Island Hospital: the impact of changing initial diabetes education from inpatient to outpatient. R I Med J (2013). 2017;100(2):21–4.

Bernier A, Fedele D, Guo Y, Chavez S, Smith MD, Warnick J, et al. New-onset diabetes educator to educate children and their caregivers about diabetes at the time of diagnosis: usability study. JMIR Diabetes. 2018;3(2): e10.

PubMed  PubMed Central  Article  Google Scholar 

Patton SR, Noser AE, Youngkin EM, Majidi S, Clements MA. Early initiation of diabetes devices relates to improved glycemic control in children with recent-onset type 1 diabetes mellitus. Diabetes Technol Ther. 2019;21(7):379–84.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Prahalad P, Addala A, Scheinker D, Hood KK, Maahs DM. CGM initiation soon after type 1 diabetes diagnosis results in sustained CGM use and wear time. Diabetes Care. 2020;43(1):e3–4.

留言 (0)

沒有登入
gif